EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen-Reference-Cited by-同舟云学术

EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen

Published:2016-05-31 Issue:3 Volume:239 Page:320-334
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Scheipl Susanne¹²,Barnard Michelle¹³⁴,Cottone Lucia¹,Jorgensen Mette¹,Drewry David H⁵⁶,Zuercher William J⁵⁶,Turlais Fabrice³,Ye Hongtao⁷,Leite Ana P¹,Smith James A³,Leithner Andreas²,Möller Peter⁸,Brüderlein Silke⁸,Guppy Naomi⁹,Amary Fernanda⁷,Tirabosco Roberto⁷,Strauss Sandra J¹,Pillay Nischalan¹⁷,Flanagan Adrienne M¹⁷⁹

Affiliation:

1. University College London Cancer Institute London UK

2. Department of Orthopaedics and Orthopaedic Surgery Medical University of Graz Austria

3. Cancer Research Technology Discovery Laboratories Cambridge UK

4. CRUK–MedImmune Alliance Laboratory Cambridge UK

5. GlaxoSmithKline Research Triangle Park NC USA

6. SGC–UNC, UNC Eshelman School of Pharmacy University of North Carolina at Chapel Hill NC USA

7. Department of Histopathology Royal National Orthopaedic Hospital Stanmore UK

8. Institute of Pathology Ulm University Germany

9. University College London Advanced Diagnostics London UK

Funder

Chordoma UK